Cite
HARVARD Citation
Danese, S. et al. (n.d.). OP40 Analysis of clinical features associated with favourable outcomes from ustekinumab treat-to-target strategy in Crohn's Disease patients in the STARDUST trial. Journal of Crohn's and colitis. p. S039. [Online].